Trading in shares of Vaultz Capital plc has officially begun on the OTCQB Venture Market, following the approval from the OTC Market Group Inc. The company’s shares will also continue to be available for trading on both the Aquis Stock Exchange and the Frankfurt Stock Exchange, bolstering its presence in multiple financial markets.
The OTCQB Venture Market is known for providing a transparent trading platform for smaller, entrepreneurial companies that meet certain criteria. These include passing a minimum bid price test, maintaining current financial reports, and participating in an annual verification and management certification process. This platform is especially beneficial for development-stage companies looking to attract investors.
Importantly, the initiation of trading on the US OTC market does not affect the trading of existing ordinary shares on the Aquis and Frankfurt exchanges. No new ordinary shares are being issued as part of this arrangement, ensuring that the existing shareholder structure remains unchanged. Furthermore, Vaultz Capital will maintain its communications through the UK’s Regulatory News Service (RNS), and the company will not be subjected to the Sarbanes-Oxley Act or SEC reporting requirements typically associated with US companies.
The CEO expressed that gaining admission to the OTCQB is a significant milestone for the company, intended to enhance its growth trajectory. This new trading option creates an accessible platform for US investors, allowing the company to broaden its international investor base. This strategic move is expected to improve the visibility of the company, increase the liquidity of its shares, and support its long-term capital planning efforts.
The management’s optimistic outlook reflects a commitment to expanding the company’s global footprint while appreciating the confidence shown by shareholders throughout this journey. This step indicates a robust vision for sustainable growth and engagement with a wider audience of potential investors.